We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
-8.84%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$391M
AUM Growth
-$55.7M
Cap. Flow
-$14.7M
Cap. Flow %
-3.76%
Top 10 Hldgs %
65.45%
Holding
31
New
2
Increased
13
Reduced
13
Closed
3

Top Buys

Rank Stock Value
1
GMED icon
Globus Medical
GMED
+$12.4M
2
BMY icon
Bristol-Myers Squibb
BMY
+$10.1M
3
GEHC icon
GE HealthCare
GEHC
+$5.69M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$4.75M
5
ELV icon
Elevance Health
ELV
+$4.44M

Top Sells

Rank Stock Value
1
BAX icon
Baxter International
BAX
+$11.9M
2
NUVA
NuVasive, Inc.
NUVA
+$11.1M
3
CAH icon
Cardinal Health
CAH
+$10.9M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$5.93M
5
BDX icon
Becton Dickinson
BDX
+$5.68M

Sector Composition

Rank Sector Weight
1 Healthcare 99.26%
2 Consumer Staples 0.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GILD icon
1
Gilead Sciences
GILD
$167B
$46.7M 11.93%
623,123
+21,756
+4% +$1.67M
BMY icon
2
Bristol-Myers Squibb
BMY
$124B
$39M 9.97%
671,780
+164,204
+32% +$10.1M
BIIB icon
3
Biogen
BIIB
$30.4B
$26.8M 6.85%
104,286
+8,529
+9% +$2.28M
MDT icon
4
Medtronic
MDT
$106B
$25.7M 6.57%
327,903
-18,605
-5% -$1.56M
INCY icon
5
Incyte
INCY
$23.4B
$25M 6.39%
432,545
+35,013
+9% +$2.21M
CAH icon
6
Cardinal Health
CAH
$53.5B
$22.9M 5.86%
264,136
-120,506
-31% -$10.9M
BDX icon
7
Becton Dickinson
BDX
$43.6B
$18.6M 4.75%
71,884
-21,039
-23% -$5.68M
ELV icon
8
Elevance Health
ELV
$80.9B
$17.9M 4.58%
41,147
+9,796
+31% +$4.44M
ZBH icon
9
Zimmer Biomet
ZBH
$17.6B
$17.9M 4.56%
159,069
+10,257
+7% +$1.3M
GEHC icon
10
GE HealthCare
GEHC
$28.7B
$15.6M 3.99%
229,589
+78,261
+52% +$5.69M
CNC icon
11
Centene
CNC
$32.8B
$15.4M 3.93%
223,148
-21,801
-9% -$1.45M
EW icon
12
Edwards Lifesciences
EW
$49.4B
$14.8M 3.77%
212,995
+17,704
+9% +$1.42M
LH icon
13
Labcorp
LH
$23.2B
$13M 3.33%
64,857
-20,236
-24% -$4.27M
GMED icon
14
Globus Medical
GMED
$10.5B
$11M 2.81%
+221,827
New +$12.4M
THC icon
15
Tenet Healthcare
THC
$16.8B
$10.4M 2.66%
157,975
-3,482
-2% -$260K
CTLT
16
DELISTED
CATALENT, INC.
CTLT
$9.43M 2.41%
207,129
+27,041
+15% +$1.26M
ALNY icon
17
Alnylam Pharmaceuticals
ALNY
$35.7B
$9.38M 2.4%
52,968
+24,901
+89% +$4.75M
BMRN icon
18
BioMarin Pharmaceuticals
BMRN
$11.5B
$8.5M 2.17%
96,048
-66,620
-41% -$5.93M
IONS icon
19
Ionis Pharmaceuticals
IONS
$8.99B
$7.51M 1.92%
165,616
+5,215
+3% +$215K
BAX icon
20
Baxter International
BAX
$11.7B
$7.29M 1.86%
193,243
-280,391
-59% -$11.9M
BRKR icon
21
Bruker
BRKR
$8.86B
$6.44M 1.65%
103,355
-8,887
-8% -$598K
RARE icon
22
Ultragenyx Pharmaceutical
RARE
$2.88B
$4.11M 1.05%
115,166
+14,561
+14% +$577K
QGEN icon
23
Qiagen
QGEN
$8.49B
$4.08M 1.04%
94,978
-25,286
-21% -$1.18M
ACAD icon
24
Acadia Pharmaceuticals
ACAD
$4.38B
$3.75M 0.96%
179,785
-20,911
-10% -$568K
LNTH icon
25
Lantheus
LNTH
$7B
$3.54M 0.91%
50,962
+653
+1% +$47.8K
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q3 2023 Portfolio in Review

As of Q3 2023, Sector Gamma AS held 31 positions worth $391M, down 12% from $447M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Sector Gamma AS withdrew a net $14.7M in Q3 2023, closing 3 positions and reducing 13 holdings. Its most notable exit was NuVasive, Inc., an estimated $11.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, down from 100% a quarter earlier, followed by Consumer Staples.

Against the trend, Sector Gamma AS opened a new position in Globus Medical worth $11M.

  • Sector Gamma AS's largest Q3 2023 buy was Globus Medical: 221,827 shares worth $11M.
  • Sector Gamma AS added most to Bristol-Myers Squibb in Q3 2023, an estimated $10.1M increase.
  • Sector Gamma AS's biggest Q3 2023 reduction was Baxter International, cutting an estimated $11.9M.
  • Sector Gamma AS fully exited NuVasive, Inc. in Q3 2023, selling an estimated $11.1M.
  • Sector Gamma AS's ten largest holdings make up 65% of its $391M portfolio in Q3 2023.
  • Sector Gamma AS opened 2 new positions and closed 3 in Q3 2023.
  • Sector Gamma AS's portfolio value fell 12% quarter-over-quarter to $391M.

Based on Sector Gamma AS's 13F filing for Q3 2023, filed 6 Nov 2023.